688068 热景生物
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)0.1520.81830.580121.89716.150
总资产报酬率 ROA (%)0.1430.73425.04696.13313.766
投入资产回报率 ROIC (%)0.1500.80028.652111.84913.971

边际利润分析
销售毛利率 (%)59.03856.95353.71159.53863.012
营业利润率 (%)4.6893.18030.67248.13424.916
息税前利润/营业总收入 (%)-2.323-5.40929.29048.15124.514
净利润/营业总收入 (%)3.0412.78126.01241.01921.673

收益指标分析
经营活动净收益/利润总额(%)-152.173-355.323117.095102.71690.402
价值变动净收益/利润总额(%)189.727-165.2281.0150.9646.378
营业外收支净额/利润总额(%)-6.702-27.437-1.454-0.101-0.413

偿债能力分析
流动比率 (X)6.2034.4763.5173.4294.079
速动比率 (X)5.4983.7463.2153.0773.202
资产负债率 (%)5.8915.68913.99221.15417.254
带息债务/全部投入资本 (%)0.2480.7572.1538.587--
股东权益/带息债务 (%)39,926.66013,048.8734,497.7711,050.88923,935.860
股东权益/负债合计 (%)1,595.8041,658.740611.307368.803476.954
利息保障倍数 (X)0.3460.684-31.106738.811-81.991

营运能力分析
应收账款周转天数 (天)24.47539.2476.7272.1390.000
存货周转天数 (天)245.051223.49845.14231.8930.000